Drawing on their diverse experience, Venable’s professionals regularly offer original perspectives on events and trends with the potential to impact our clients. Explore our insights.
Regulatory and litigation developments for advertisers and marketers.
Interactive database of aBLA activity, USPTO post grant proceedings and patent litigations for CDER-listed / 505(b)(2) biologic drugs and cellular and gene therapies, including company news, regulatory updates and statistical analysis
Subscribe to receive the latest news from us